Lallemand Health Solutions is pleased to announce its partnership with Prader-Willi syndrome association (PWS) | USA, and “Running for Research,” a charitable initiative to raise funds…
Lallemand Health Solutions will officially launch ROSELLA, its new highly documented licensed strain for Women’s intimate health at Vitafoods Europe Virtual Expo…
Lallemand Health Solutions and Proge Farm® are proud to announce that they have just closed a major licensing deal for the commercialization…
As an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S.…
Lallemand Health Solutions launches the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52…
Lallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed…
The Lallemand group, in partnership with Biotechnologies Ulysse and Bio-K Plus, all Canadian companies, are joining forces to develop a vaccine against…
The Lallemand group is donating 3,200 surgical and N95 masks to local health authorities in the Montreal (Canada) and Cantal (France) regions,…
With the rapidly evolving COVID-19 pandemic, Lallemand Health Solutions (LHS) further deployed additional measures to its initial contingency plan, to ensure employees…
One of Lallemand Health Solution’s documented strains, Bifidobacterium lactis Lafti® B94 has recently received a No Questions Letter (NQL) regarding the Generally…
